Insulet Corporation (PODD)
NASDAQ · Healthcare
Insulet Corporation Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 2.71B | 2.07B | 1.70B | 1.06B | 1.04B | 904.4M | 738.2M | 563.8M | 463.8M | 367.0M | 263.9M | 231.3M | 247.1M | 211.4M | 152.3M | 97.0M | 66.0M |
| Gross Profit | 1.94B | 1.45B | 1.16B | 805.6M | 752.1M | 582.3M | 480.3M | 370.2M | 277.2M | 211.1M | 133.3M | 127.1M | 112.4M | 92.3M | 66.7M | 43.7M | 18.3M |
| Profitability | |||||||||||||||||
| Operating Income | 473.8M | 308.9M | 220.1M | 37.6M | 126.0M | 51.5M | 50.0M | 27.4M | -7.4M | -10.7M | -48.7M | -8.9M | -29.1M | -36.0M | -42.5M | -38.6M | -59.4M |
| EBITDA | 564.2M | 389.7M | 292.9M | 100.8M | 183.4M | 106.9M | 77.9M | 43.0M | 6.5M | 3.1M | -32.9M | 3.3M | -17.3M | -24.9M | -34.0M | -33.6M | -54.1M |
| Net Income | 247.1M | 418.3M | 206.3M | 4.6M | 16.8M | 6.8M | 11.6M | 3.3M | -26.8M | -28.9M | -73.5M | -51.5M | -45.0M | -51.9M | -45.8M | -61.2M | -72.3M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 72M | 74M | 74M | 70M | 69M | 66M | 62M | 61M | 58M | 57M | 57M | 56M | 55M | 48M | 48M | 45M | — |
Insulet Corporation Income Statement — FAQ
Insulet Corporation (PODD) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PODD's income statement history?
The chart and table above show Insulet Corporation's income statement by year and by quarter, including the growth rate.